| Use of antimony in the treatment of leishmaniasis: current status and future directions AK Haldar, P Sen, S Roy Molecular biology international 2011, 2011 | 440 | 2011 |
| Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and-resistant strains of Leishmania donovani that … R Basu, S Bhaumik, JM Basu, K Naskar, T De, S Roy The journal of immunology 174 (11), 7160-7171, 2005 | 293 | 2005 |
| Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in … J Mookerjee Basu, A Mookerjee, P Sen, S Bhaumik, P Sen, S Banerjee, ... Antimicrobial agents and chemotherapy 50 (5), 1788-1797, 2006 | 206 | 2006 |
| Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts D Chakraborty, S Banerjee, A Sen, KK Banerjee, P Das, S Roy The Journal of Immunology 175 (5), 3214-3224, 2005 | 156 | 2005 |
| Leishmania donovani Suppresses Activated Protein 1 and NF-κB Activation in Host Macrophages via Ceramide Generation: Involvement of Extracellular Signal … S Ghosh, S Bhattacharyya, M Sirkar, GS Sa, T Das, D Majumdar, S Roy, ... Infection and Immunity 70 (12), 6828-6838, 2002 | 156 | 2002 |
| Chemokine-induced leishmanicidal activity in murine macrophages via the generation of nitric oxide S Bhattacharyya, S Ghosh, B Dasgupta, D Mazumder, S Roy, S Majumdar The Journal of infectious diseases 185 (12), 1704-1708, 2002 | 97 | 2002 |
| Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1 B Mukherjee, R Mukhopadhyay, B Bannerjee, S Chowdhury, S Mukherjee, ... Proceedings of the National Academy of Sciences 110 (7), E575-E582, 2013 | 92 | 2013 |
| Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype? M Vanaerschot, F Dumetz, S Roy, A Ponte-Sucre, J Arevalo, JC Dujardin Expert review of anti-infective therapy 12 (8), 937-946, 2014 | 87 | 2014 |
| KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major S Bhaumik, R Basu, S Sen, K Naskar, S Roy Vaccine 27 (9), 1306-1316, 2009 | 79 | 2009 |
| Mapping the Antigenicity of the Parasites in Leishmania donovani Infection by Proteome Serology M Forgber, R Basu, K Roychoudhury, S Theinert, S Roy, S Sundar, ... PloS one 1 (1), e40, 2006 | 77 | 2006 |
| Generation of ceramide in murine macrophages infected with Leishmania donovani alters macrophage signaling events and aids intracellular parasitic survival S Ghosh, S Bhattacharyya, S Das, S Raha, N Maulik, DK Das, S Roy, ... Molecular and Cellular Biochemistry 223, 47-60, 2001 | 77 | 2001 |
| Restoration of IFNγR Subunit Assembly, IFNγ Signaling and Parasite Clearance in Leishmania donovani Infected Macrophages: Role of Membrane Cholesterol S Sen, K Roy, S Mukherjee, R Mukhopadhyay, S Roy PLoS pathogens 7 (9), e1002229, 2011 | 75 | 2011 |
| Vaccination with Leishmania Hemoglobin Receptor–Encoding DNA Protects Against Visceral Leishmaniasis R Guha, D Gupta, R Rastogi, R Vikram, G Krishnamurthy, S Bimal, S Roy, ... Science Translational Medicine 5 (202), 202ra121-202ra121, 2013 | 70 | 2013 |
| A review on potential of natural products in the management of COVID-19 R Chakravarti, R Singh, A Ghosh, D Dey, P Sharma, R Velayutham, S Roy, ... RSC advances 11 (27), 16711-16735, 2021 | 65 | 2021 |
| Imipramine Is an Orally Active Drug against Both Antimony Sensitive and Resistant Leishmania donovani Clinical Isolates in Experimental Infection S Mukherjee, B Mukherjee, R Mukhopadhyay, K Naskar, S Sundar, ... PLoS neglected tropical diseases 6 (12), e1987, 2012 | 64 | 2012 |
| Immunoprophylaxis and immunotherapy against experimental visceral leishmaniasis S Mukhopadhyay, P Sen, S Bhattacharyya, S Majumdar, S Roy Vaccine 17 (3), 291-300, 1999 | 63 | 1999 |
| Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol [S] J Ghosh, S Das, R Guha, D Ghosh, K Naskar, A Das, S Roy Journal of Lipid Research 53 (12), 2560-2572, 2012 | 62 | 2012 |
| Sub-optimal dose of sodium antimony gluconate (SAG)-diperoxovanadate combination clears organ parasites from BALB/c mice infected with antimony resistant Leishmania donovani by … AK Haldar, S Banerjee, K Naskar, D Kalita, NS Islam, S Roy Experimental Parasitology 122 (2), 145-154, 2009 | 56 | 2009 |
| Validation of a simple resazurin-based promastigote assay for the routine monitoring of miltefosine susceptibility in clinical isolates of Leishmania donovani A Kulshrestha, V Bhandari, R Mukhopadhyay, V Ramesh, S Sundar, ... Parasitology research 112, 825-828, 2013 | 54 | 2013 |
| Epigenetic modification and therapeutic targets of diabetes mellitus R Singh, S Chandel, D Dey, A Ghosh, S Roy, V Ravichandiran, D Ghosh Bioscience reports 40 (9), BSR20202160, 2020 | 52 | 2020 |
